ACC takes substantial 5.2% stake in EBOS Group

EBOS Group Limited ( (AU:EBO) ) just unveiled an announcement.

New Zealand’s Accident Compensation Corporation (ACC) has disclosed that it has begun a substantial holding in EBOS Group, accumulating 10,737,285 ordinary shares across the NZX and ASX, representing 5.237% of the company’s total shares on issue. ACC’s position, held beneficially through the New Zealand Central Securities Depository and J.P. Morgan Nominees Australia, reflects a series of on-market purchases and smaller sales between November 2025 and March 2026, signalling a significant institutional endorsement that may enhance market confidence and liquidity in EBOS shares.

Over the period from 20 November 2025 to 20 March 2026, ACC purchased nearly 1.94 million NZX-listed EBOS shares for about NZ$48.2 million and 521,180 ASX-listed shares for roughly A$9.7 million, while selling a comparatively minor volume on both exchanges. The move formally elevates ACC to substantial product holder status under New Zealand securities law, highlighting growing institutional interest in EBOS and potentially strengthening the company’s shareholder base ahead of future strategic or capital market developments.

The most recent analyst rating on (AU:EBO) stock is a Buy with a A$30.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.

More about EBOS Group Limited

EBOS Group Limited is a dual-listed company on the NZX and ASX, with ordinary shares trading under the tickers EBO NZ and EBO AU. The company operates in the healthcare and pharmaceutical distribution sector, supplying products and services across Australasian markets to a range of healthcare providers and related customers.

Average Trading Volume: 162,212

Technical Sentiment Signal: Sell

Current Market Cap: A$3.72B

For detailed information about EBO stock, go to TipRanks’ Stock Analysis page.